SIX:SANN

Santhera Pharmaceuticals Holding AG · SIX · Healthcare · CHF · FY for 2025

Figures on this page computed 2026-11-08 12:56 UTC

Last close

n/aCHF

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -63.8%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -45.1%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CHF
    • computed

All from 100

lens 2 of 9

Sales

1,786
2015-12-31 to 2025-12-31100 at the start1,786
Sales: 100.00 on 2015-12-31 to 1786.28 on 2025-12-31, up 1686%.

Profit

-828
2015-12-31 to 2025-12-31100 at the start-828
Profit: 100.00 on 2015-12-31 to -827.63 on 2025-12-31, down 928%.

Shares in issue

2,373
2015-12-31 to 2025-12-31100 at the start2,373
Shares in issue: 100.00 on 2015-12-31 to 2373.40 on 2025-12-31, up 2273%.

Sales is at 1786, Profit is at -828, Shares in issue is at 2373, against 100 in 2015.

Sales is at 1786, Profit is at -828, Shares in issue is at 2373, against 100 in 2015.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales, where the first year is 1001,786
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Profit, where the first year is 100-828
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF
  • Shares in issue, where the first year is 1002,373
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CHF

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.